Nanoparticle-based systems present a promising strategy to enhance the effectiveness of cancer therapies by selectively influencing the PI3K/AKT/mTOR pathway and other tumor-promoting processes, thereby overcoming the limitations of conventional treatments [30]. This evidence concerns the gene AKT1 and neoplasm.